Rockwell Medical, Inc. Appoints Pharmaceutical Industry Leader Robert S. Radie to Board of Directors
WIXOM, Mich., March 31, 2020 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, announced today ... [Read]
Rockwell Medical Receives FDA Approval: Stock Sees 6% Growth
Followers of Rockwell Medical Inc. (NASDAQ:RMTI) have reason to celebrate today, as does the medical community. The Michigan-based biopharmaceutical company announced today that it received FDA approval for the intravenous formulation of its novel, physiologic ... [Read]
Is RockWell Medical (NASDAQ:RMTI) a Good Buy Right Now?
Biopharmaceutical company Rockwell Medical, Inc. (NASDAQ:RMTI) increased by 1.22% to US$2.48 just minutes into after-hours trading on Wednesday after closing at US$2.45, bringing its market cap to US$169 million. Throughout the day Wednesday, RMTI experienced ... [Read]
4 Top Small-Cap Biotech Stocks Approaching FDA Approval
In 1992, Congress passed the Prescription Drug User Fee Act (PDUFA), which allows the US Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the drug review and approval process. The ... [Read]